Advancing Precision Anesthesia with Modern Bioanalytical Methods

Propofol is the most widely used intravenous anesthetic agent in modern clinical practice. However, doctors often face challenges due to the significant interindividual variability in how patients respond to the drug. To address these variations, researchers have developed a high-throughput method for plasma propofol quantification. This advancement is essential because current population-based dosing algorithms often fail to provide the precision required for every surgical patient.

The Efficiency of Plasma Propofol Quantification

Specifically, the study details a new liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay. This method utilizes protein precipitation to achieve a rapid total run-time of only 5.5 minutes. Furthermore, the assay demonstrates remarkable accuracy and stability across a broad quantification range of 25 to 5000 ng/mL. Consequently, this reliable tool allows for the efficient processing of large-scale samples in clinical pharmacokinetic studies. Additionally, the method remains robust even under various storage and handling conditions, ensuring data integrity.

Refining Target-Controlled Infusion Algorithms

The primary utility of this bioanalytical method lies in its ability to inform pharmacokinetic-pharmacodynamic modeling. By providing accurate plasma propofol quantification data, the assay helps refine Target-Controlled Infusion (TCI) algorithms. As a result, anesthesiologists can develop more individualized dosing strategies for patients undergoing major noncardiac surgery. In conclusion, this fit-for-purpose method significantly supports the transition toward more personalized and safer anesthetic management.

Frequently Asked Questions

Why is plasma propofol quantification important in clinical research?

It allows researchers to precisely measure drug concentrations, which is vital for creating accurate dosing models that account for individual patient differences.

What are the technical advantages of the new LC-MS/MS assay?

The assay is highly efficient with a 5.5-minute run-time and offers high extraction recovery. It also remains stable under various conditions like freeze-thaw cycles and long-term storage.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Ng MKL et al. Development and Application of an LC-MS/MS Assay for Plasma Propofol Quantification in Major Noncardiac Surgical Patients to Evaluate Target-Controlled Infusion Algorithms. Ther Drug Monit. 2026 May 29. doi: 10.1097/FTD.0000000000001474. PMID: 42214089.


2. Sahinovic MM, Struys MMRF, Absalom AR. Clinical Pharmacokinetics and Pharmacodynamics of Propofol. Clin Pharmacokinet. 2018;57(12):1539-1558.


3. Eleveld DJ, Colin P, Absalom AR, Struys MMRF. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br J Anaesth. 2018;120(5):942-959.